AbbVie Rises on First Day of Trading After Abbott Spinoff

Abbott Laboratories and its drug-company spinoff AbbVie Inc. both gained as their shares traded on the open market for the first time as separate businesses.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.